Prevalence and Clinical Impact of Minority Resistant Variants in Patients Failing an Integrase Inhibitor-Based Regimen by Ultra-Deep Sequencing - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Journal of Antimicrobial Chemotherapy Année : 2018

Prevalence and Clinical Impact of Minority Resistant Variants in Patients Failing an Integrase Inhibitor-Based Regimen by Ultra-Deep Sequencing

Dates et versions

hal-03704030 , version 1 (24-06-2022)

Identifiants

Citer

T Nguyen, D B Fofana, M P Lê, C Charpentier, G Peytavin, et al.. Prevalence and Clinical Impact of Minority Resistant Variants in Patients Failing an Integrase Inhibitor-Based Regimen by Ultra-Deep Sequencing. Journal of Antimicrobial Chemotherapy, 2018, 73 (9), pp.2485--2492. ⟨10.1093/jac/dky198⟩. ⟨hal-03704030⟩
7 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More